3.00 |
Decreased IgA levels |
No |
|
|
3.00 |
Decreased IgG levels |
No |
|
|
3.00 |
Decreased IgM levels |
No |
|
|
2.00 |
Reduced number of B cells |
Yes |
|
|
2.00 |
Neutropenia |
Yes |
|
|
2.00 |
Reduced proportion of naive CD4 T cells |
Yes |
|
|
3.00 |
Increased proportion of effector mem. CD8 T cells |
Yes |
|
|
3.00 |
Reduced proportion of CD4 T cells |
Yes |
|
|
2.00 |
Reduced proportion of naive CD8 T cells |
Yes |
|
|
0.17 |
Seizures |
Yes |
severe |
recurrent |
3.00 |
B-cell lymphoma |
Yes |
severe |
acute |
2.00 |
Thrombocytopenia |
Yes |
|
|
Unk. |
Gastroesophageal reflux |
Yes |
mild |
|
2.00 |
Lymphopenia |
Yes |
|
|
2.00 |
Anemia |
Yes |
|
|
3.00 |
(unusual) Epstein-Barr virus infection |
Yes |
|
|
2.00 |
Hepatomegaly |
Yes |
|
|
3.00 |
(unusual) Cytomegalovirus infection |
Yes |
|
|
2.00 |
Cervical lymphadenopathy |
Yes |
|
chronic |
2.00 |
Elevated C-reactive protein |
Yes |
|
|
3.00 |
Increased proportion of effector mem. CD4 T cells |
Yes |
|
|
Unk. |
Muscular hypotonia |
Yes |
|
|
0.01 |
Progressive microcephaly |
Yes |
severe |
|
Unk. |
Optic atrophy |
Yes |
|
|
Unk. |
Global developmental delay |
Yes |
|
|
0.01 |
Intellectual disability, profound |
Yes |
severe |
|
3.00 |
Immunodeficiency |
Yes |
|
|
2.00 |
Decreased serum complement C3 |
Yes |
|
|
Unk. |
Brain atrophy |
Yes |
|
|
2.00 |
Decreased lymphocyte proliferation in response to mitogens |
Yes |
|
|
Unk. |
Cerebral visual impairment |
Yes |
|
|